BIS
ProShares UltraShort Nasdaq Biotechnology
Set alert
10.47 USD +0.01 +0.08%
10.06 Day range 10.55
10.46 52-week range 22.70
- YTD
- -44.78%
- 1 year
- -52.89%
- Open
- 10.41
- Prev close
- 10.46
- Mkt cap
- 1.73M
- Vol
- 13.07K
- Avg vol
- 9.16K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.06
- High
- 10.55
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 16.07
- 200-d avg
- 16.53
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 16.07
- 200-day average
- 16.53
About ProShares UltraShort Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
- TD Touts Successful Tokenized Payments With Project Agorá
- BIS says AI boom risks clouding central banks' inflation signals
- BIS dares to blaspheme as AI bubble fears wane
- BIS says debt, AI boom and fragilities raise global risks
- Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules
- Retail traders using leveraged ETFs were a major driver of January's dramatic gold and silver selloff – BIS
- Applied Materials Reaches Resolution with the U.S. Department of Commerce
- BIS says gold and equities are in bubble territory
- Central bank body BIS raises concerns of gold and stocks double bubble
- Can Energy Transfer Gain From BIS' Current Stance on Ethane Export?
Your note
Sign in to keep a note on BIS — it syncs with the Stock Master app.